DP
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Early-phase 18F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer’s disease: a comparison with 18F-FDG-PET and early-phase amyloid-PET | European journal of nuclear medicine and molecular imaging | 2025 | 13 | 16 | |||
| Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment | European journal of nuclear medicine and molecular imaging | 2025 | 15 | 97 | |||
| Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline | Brain | 2024 | 7 | 14 | |||
| A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | 2024 | 86 | 52 | |||
| The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline | Alzheimer's & dementia | 2024 | 123 | 103 | |||
| Automatic Classification of Conclusions from Multi-Tracer Reports of PET Brain Imaging in Cognitive Impairment | Studies in health technology and informatics | 2024 | 147 | 72 | |||
| Prognostic value of imaging-based ATN profiles in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | 2023 | 96 | 56 | |||
| ATN profile classification across two independent prospective cohorts | Frontiers in medicine | 2023 | 132 | 71 | |||
| Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways | European journal of nuclear medicine and molecular imaging | 2023 | 112 | 44 | |||
| Early-phase 18F-Florbetapir and 18F-Flutemetamol images as proxies of brain metabolism in a memory clinic setting | The Journal of nuclear medicine | 2023 | 177 | 138 |
